Myocardial and cerebral infarction as initial presentation of antiphospholipid syndrome;Infarto miocardico e cerebrale come presentazione iniziale di una sindrome da anticorpi antifosfolipidi

Giornale Italiano di Cardiologia

Volumn 10, Issue 4, 2009, Pages 259-262

  Patrignani, Anna ^a   Nannicosta, Maria Paola ^a   Antonini, Luca ^a   D'Aroma, Alessandro ^a   De Berardinis, Giovanni ^a   Cicogna, Sabrina ^a  

^a SAN SALVATORE HOSPITAL   (Italy)

Author keywords

Antiphospolipid syndrome; Thrombophilia; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; CLOPIDOGREL; WARFARIN;

ADULT; ANGIOCARDIOGRAPHY; ANTIBODY DETECTION; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIZZINESS; DRUG ELUTING STENT; ECG ABNORMALITY; FEMALE; HEART INFARCTION; HUMAN; LABORATORY TEST; NAUSEA; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION; SWELLING; VOMITING;

ANTIPHOSPHOLIPID SYNDROME; CEREBRAL INFARCTION; FEMALE; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 65349175920     PISSN: 18276806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Sinico RA, Di Toma L, Sabadini E, Renoldi P, Li Vecchi M. Catastrophic antiphospholipid syndrome: report of 4 cases. J Nephrol 2007; 20: 739-44.
2. Etsuda H, Miyamoto A, Nakajima Y, et al. Acute myocardial infarction with variable clinical manifestations: probable catastrophic primary antiphospholipid antibody syndrome: a case report. J Cardiol 2005; 46: 155-60.
3. Sherer Y, Blank M, Shoenfeld Y. Antiphospholipid syndrome (APS): where does it come from? Best Pract Res Clin Rheumatol 2007; 21: 1071-8.
4. Jiménez S, Tàssies D, Espinosa G, et al. Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/ IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus. Ann Rheum Dis 2008; 67: 835-40.
5. Bernales I, Fullaondo A, Marin-Vidalled MJ, et al. Innate immune response gene expression profiles characterize primary antiphospholipid syndrome. Genes Immun 2008; 9: 38-46.
6. Tenedios F, Erkan D, Lockshin MD. Cardiac manifestations in the antiphospholipid syndrome. Rheum Dis Clin North Am 2006; 32: 491-507.
7. Salmon JE, de Groot PG. Pathogenic role of antiphospholipid antibodies. Lupus 2008; 17: 405-11.
8. Jara LJ, Medina G, Vera-Lastra O. Systemic antiphospholipid syndrome and atherosclerosis. Clin Rev Allergy Immunol 2007; 32: 172-7.
9. Vaccaro F, Caccavo D, Roumpedaki E, et al. Dilated cardiomyopathy due to thrombotic microangiopathy as the only manifestation of antiphospholipid syndrome: a case report. Int J Immunopathol Pharmacol 2008; 21: 237-41.
10. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.